These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 12806558

  • 21. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME, Alborzi S, Jahromi BN.
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [Abstract] [Full Text] [Related]

  • 22. Risk of multiple gestation after ovulation induction in polycystic ovary syndrome.
    Ratts VS, Pauls RN, Pinto AB, Kraja A, Williams DB, Odem RR.
    J Reprod Med; 2007 Oct; 52(10):896-900. PubMed ID: 17977162
    [Abstract] [Full Text] [Related]

  • 23. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
    Wu HH, Wang NM, Cheng ML, Hsieh JN.
    Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
    [Abstract] [Full Text] [Related]

  • 24. Letrozole vs. clomiphene citrate in patients with ovulatory infertility.
    Bayar U, Tanriverdi HA, Barut A, Ayoğlu F, Ozcan O, Kaya E.
    Fertil Steril; 2006 Apr; 85(4):1045-8. PubMed ID: 16580393
    [Abstract] [Full Text] [Related]

  • 25. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.
    Saleh AM, Khalil HS.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):614-21. PubMed ID: 15225184
    [Abstract] [Full Text] [Related]

  • 26. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
    Eckmann KR, Kockler DR.
    Ann Pharmacother; 2009 Jul; 43(7):1338-46. PubMed ID: 19584394
    [Abstract] [Full Text] [Related]

  • 27. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
    Bordewijk EM, Weiss NS, Nahuis MJ, Bayram N, van Hooff MHA, Boks DES, Perquin DAM, Janssen CAH, van Golde RJT, Lambalk CB, Goddijn M, Hompes PG, van der Veen F, Mol BWJ, van Wely M, M-ovin study group.
    Hum Reprod; 2019 Feb 01; 34(2):276-284. PubMed ID: 30576539
    [Abstract] [Full Text] [Related]

  • 28. Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.
    Budinetz TH, Benadiva CA, Griffin DW, Engmann LL, Nulsen JC, DiLuigi AJ.
    Fertil Steril; 2015 Mar 01; 103(3):675-9. PubMed ID: 25577463
    [Abstract] [Full Text] [Related]

  • 29. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility.
    van Santbrink EJ, Eijkemans MJ, Laven JS, Fauser BC.
    Trends Endocrinol Metab; 2005 Oct 01; 16(8):381-9. PubMed ID: 16129615
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
    Tao Y, Dai Q, Zhang D.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep 01; 34(9):528-32. PubMed ID: 11360636
    [Abstract] [Full Text] [Related]

  • 31. A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate.
    Roy KK, Baruah J, Sharma A, Sharma JB, Kumar S, Kachava G, Karmakar D.
    Arch Gynecol Obstet; 2010 May 01; 281(5):939-44. PubMed ID: 19956961
    [Abstract] [Full Text] [Related]

  • 32. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May 01; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 33. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupThessaloniki 54603, Greece..
    Hum Reprod; 2008 Mar 01; 23(3):462-77. PubMed ID: 18308833
    [Abstract] [Full Text] [Related]

  • 34. Dexamethasone in unexplained infertility.
    Moradan S, Ghorbani R.
    Saudi Med J; 2009 Aug 01; 30(8):1034-6. PubMed ID: 19668883
    [Abstract] [Full Text] [Related]

  • 35. Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.
    Bayram N, van Wely M, van der Veen F, Bossuyt PM, Nieuwkerk P.
    Fertil Steril; 2005 Aug 01; 84(2):420-5. PubMed ID: 16084884
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate.
    Kato M, Kikuchi I, Shimaniki H, Kobori H, Aida T, Kitade M, Kumakiri J, Takeuchi H.
    J Obstet Gynaecol Res; 2007 Apr 01; 33(2):174-80. PubMed ID: 17441891
    [Abstract] [Full Text] [Related]

  • 39. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF, Hughes GJ, Garrett DK, Hanjani A, Steigrad SJ.
    Int J Fertil Womens Med; 1998 Apr 01; 43(1):28-33. PubMed ID: 9532467
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.